In another study by Le et al., poly(β-aminoester) (PBAE)NPs were prepared to deliver bevacizumab-encoded synthetic mRNA asan anti-VEGF antibody therapy for the treatment of nonsmall cell lungcancer (NSCLC). The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.